EUVIMEDEUVIMED entdecken
Crossref

Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States

Chenxi Jiang iD, Rachel A Freedman, Rinaa S Punglia, Ahmedin Jemal iD, Hyuna Sung iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Chenxi Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance & Health Equity Science, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Lung Neoplasms, Cancer Survivors, Neoplasms, Second Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Intramural Research Department of the American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy for breast cancer has been associated with an increased risk of secondary malignancies, including primary lung cancer. Whether this association varies by histological subtype of lung cancer remains unknown. Based on the data from 12 Surveillance, Epidemiology, and End Results registries, we examined the association between radiotherapy receipt and the risk of subtype‐specific subsequent primary lung cancer (SPLC) among female first primary breast cancer cases diagnosed between ages 20 and 84 from 1992 to 2020. More than half (53%) of the 550,007 breast cancer survivors identified had undergone radiotherapy as part of their initial breast cancer treatment. Over an average follow‐up of 9.7 years, 8014 survivors developed SPLCs. For small‐cell carcinoma, the standardized incidence ratio (SIR) compared with the general population was higher for survivors who received radiotherapy (SIR = 1.15, 95% confidence interval [CI] = 1.06–1.25) but similar for those who did not receive radiotherapy (SIR = 1.00, 95% CI = 0.91–1.09), with the difference in SIRs being statistically significant ( p = .003). Similar associations were found for squamous cell carcinoma (SIR yes = 1.16, 95% CI = 1.08–1.24 vs. SIR no/unknown = 1.06, 95% CI = 0.98–1.15; p = .07). The increased risks were confined to ipsilateral SPLC, with the greatest SIRs for small‐cell carcinoma occurring 5–10 years since breast cancer diagnosis (SIR = 1.83, 95% CI = 1.53–2.19) and for squamous cell carcinoma with a latency of 10 years or more (SIR = 1.64, 95% CI = 1.42–1.88). In contrast, the risk of developing adenocarcinoma did not vary by radiotherapy receipt (SIR yes = 1.23, 95% CI = 1.18–1.28 vs. SIR no/unknown = 1.17, 95% CI = 1.12–1.22; p = .18), indicating additional risk factors in play. The findings suggest a distinct carcinogenic pathway of radiation‐induced lung cancer across histological subtypes and may inform risk‐stratified surveillance guidelines for SPLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLung NeoplasmsCancer SurvivorsNeoplasms, Second PrimaryNeoplasms, Radiation-InducedHumansFemaleMiddle AgedAgedUnited StatesAdultAged, 80 and overSEER ProgramYoung AdultIncidenceRisk FactorsSmall Cell Lung CarcinomaRadiotherapyFollow-Up Studies

Stichwörter der Autor:innen

breast cancer survivorshistological subtyperadiotherapysubsequent primary lung cancer

Autor:innen und Institutionen

  • Surveillance & Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Chenxi Jiang, Ahmedin Jemal, Hyuna Sung

Förderung

  • Intramural Research Department of the American Cancer Society

Zitieren

APA

Jiang, C., Freedman, R. A., Punglia, R. S., Jemal, A., & Sung, H. (2025). Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States. International Journal of Cancer. https://doi.org/10.1002/ijc.35257

Vancouver

Jiang C, Freedman RA, Punglia RS, Jemal A, Sung H. Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States. International Journal of Cancer. 2025. doi:10.1002/ijc.35257

BibTeX
@article{Jiang2025,
  author = {Jiang, Chenxi and Freedman, Rachel A and Punglia, Rinaa S and Jemal, Ahmedin and Sung, Hyuna},
  title = {Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35257}
}
Kostenlos starten →